Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus P Hoeflich

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Plos One|June 4, 2009
Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumorsBijay S Jaiswal, Vasantharajan Janakiraman, Noelyn M Kljavin, et al.
Journal of the American Society of Nephrology : JASN|March 3, 2022
Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney DiseaseXiaofang Wang, Li Jiang, Ka Thao, et al.
BMC Biotechnology|September 28, 2007
pHUSH: a single vector system for conditional gene expressionDaniel C Gray, Klaus P Hoeflich, Li Peng, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Phosphoproteomic characterization of DNA damage response in melanoma cells following MEK/PI3K dual inhibitionDonald S Kirkpatrick, Daisy J Bustos, Taner Dogan, et al.
Oncotarget|January 19, 2015
Group I Paks as therapeutic targets in NF2-deficient meningiomaHoi-Yee Chow, Biao Dong, Sergio G Duron, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Machine Learning ADME Models in Practice: Four Guidelines from a Successful Lead Optimization Case StudyAlexander S Rich, Yvonne H Chan, Benjamin Birnbaum, et al.
International Journal of Oncology|September 12, 2006
Regulation of ERK3/MAPK6 expression by BRAFKlaus P Hoeflich, Michael T Eby, William F Forrest, et al.
Molecular & Cellular Proteomics : MCP|April 24, 2013
Systems-wide analysis of K-Ras, Cdc42, and PAK4 signaling by quantitative phosphoproteomicsFlorian Gnad, Amy Young, Wei Zhou, et al.
The Journal of Biological Chemistry|June 29, 2017
Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycleTaner Dogan, Florian Gnad, Jocelyn Chan, et al.
Cancer Research|November 16, 2011
Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibitionKlaus P Hoeflich, Mark Merchant, Christine Orr, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Plos One|June 4, 2009
Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumorsBijay S Jaiswal, Vasantharajan Janakiraman, Noelyn M Kljavin, et al.
Journal of the American Society of Nephrology : JASN|March 3, 2022
Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney DiseaseXiaofang Wang, Li Jiang, Ka Thao, et al.
BMC Biotechnology|September 28, 2007
pHUSH: a single vector system for conditional gene expressionDaniel C Gray, Klaus P Hoeflich, Li Peng, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Phosphoproteomic characterization of DNA damage response in melanoma cells following MEK/PI3K dual inhibitionDonald S Kirkpatrick, Daisy J Bustos, Taner Dogan, et al.
Oncotarget|January 19, 2015
Group I Paks as therapeutic targets in NF2-deficient meningiomaHoi-Yee Chow, Biao Dong, Sergio G Duron, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Machine Learning ADME Models in Practice: Four Guidelines from a Successful Lead Optimization Case StudyAlexander S Rich, Yvonne H Chan, Benjamin Birnbaum, et al.
International Journal of Oncology|September 12, 2006
Regulation of ERK3/MAPK6 expression by BRAFKlaus P Hoeflich, Michael T Eby, William F Forrest, et al.
Molecular & Cellular Proteomics : MCP|April 24, 2013
Systems-wide analysis of K-Ras, Cdc42, and PAK4 signaling by quantitative phosphoproteomicsFlorian Gnad, Amy Young, Wei Zhou, et al.
The Journal of Biological Chemistry|June 29, 2017
Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycleTaner Dogan, Florian Gnad, Jocelyn Chan, et al.
Cancer Research|November 16, 2011
Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibitionKlaus P Hoeflich, Mark Merchant, Christine Orr, et al.
Pageof 7